| Literature DB >> 35354044 |
Seeun Oh1, Kai Li2, Alexander Prince2, Matthew L Wheeler2, Hussein Hamade3, Christopher Nguyen2, Kathrin S Michelsen4, David M Underhill5.
Abstract
Dectin-1 recognizes β-glucan in fungal cell walls, and activation of Dectin-1 in dendritic cells (DCs) influences immune responses against fungi. Although many studies have shown that DCs activated via Dectin-1 induce different subsets of T helper cells according to different cytokine milieus, the mechanisms underlying such differences remain unknown. By harnessing polymorphic Candida albicans and polystyrene beads of different sizes, we find that target size influences production of cytokines that control differentiation of T helper cell subsets. Hyphal C. albicans and large beads activate DCs but cannot be phagocytosed due to their sizes, which prolongs the duration of Dectin-1 signaling. Transcriptomic analysis reveals that expression of Il33 is significantly increased by larger targets, and increased IL-33 expression promotes TH9 responses. Expression of IL-33 is regulated by the Dectin-1-SYK-PLCγ-CARD9-ERK pathway. Altogether, our study demonstrates that size of fungi can be a determining factor in how DCs induce context-appropriate adaptive immune responses.Entities:
Keywords: C-type lectin receptor; CD4 T cell differentiation; CP: Immunology; CP: Microbiology; dendritic cell; frustrated phagocytosis; hyphae; yeast
Mesh:
Substances:
Year: 2022 PMID: 35354044 PMCID: PMC9052946 DOI: 10.1016/j.celrep.2022.110567
Source DB: PubMed Journal: Cell Rep Impact factor: 9.995
Figure 1.Different morphology of C. albicans induces differential activation of DCs in TH cell polarization
(A) Experimental plan for in vitro DC:OT-II T cell co-culture.
(B) DCs were stimulated with yeast-locked (YLCA) or hyphae-locked (HLCA) C. albicans, pulsed with Ova peptide (323–339), and co-cultured with naïve Rag OT-II CD4+ T cells. Production of IFNγ, IL-13, or IL-9 was assessed by ELISA. n = 5 biological replicates.
(C) Fluorescence imaging of DCs engaging C. albicans yeast and hyphae 10 min after addition of fungi. Phosphorylated SYK was visualized at the site of fungal contact by immunofluorescence. Actin and nuclei were visualized with phalloidin and 4’,6-diamidino-2-phenylindole (DAPI), respectively. Arrows indicate locations of yeast and hyphae, and dotted line indicates edges of the DCs.
(D) DCs were stimulated with LPS, yeast or hyphal C. albicans, pulsed with Ova peptide (323–339), and co-cultured with naïve Rag OT-II CD4+ T cells. Production of IL-9 was assessed by ELISA. n = 5 biological replicates.
(E) DCs were stimulated with LPS, yeast or hyphal C. albicans, and co-cultured with wild-type naïve CD4+ T cells. Production of IL-9 was assessed by ELISA. n = 4 biological replicates.
Results are mean ± SD analyzed using one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.005, ***p < 0.0005; not significant if it is not denoted.
Figure 2.TH9 polarization in DCs stimulated with large targets is dependent on Dectin-1 and CARD9
(A) Fluorescence imaging of YLCA or HLCA. β-glucan was visualized with soluble murine Dectin-1 receptor fused to human IgG1 Fc(sDectin-1),and recombinant human IgG1 Fc was used as a control.
(B–D) Wild-type or (B) Clec7a−/−, (C) Clec4n−/−, or (D) Card9−/− DCs were stimulated with YLCA or HLCA, pulsed with Ova peptide (323–339), and co-cultured with naïve Rag−/− OT-II CD4+ T cells. Production of IL-9 was assessed by ELISA. (B and D) n = 3 biological replicates. (C) n = 6 biological replicates.
(E) Wild-type or Clec7a−/− DCs were stimulated with 3, 6, 15, 25, or 45 μm polystyrene beads that were coated with BSA, mannan, or β-glucan overnight and pulsed with Ova peptide (323–339) for 2 h prior to being co-cultured with naïve Rag−/− OT-II CD4+ T cells. Production of IL-9 was assessed by ELISA. n = 6 biological replicates.
(F) Confocal images showing how DCs process the beads according to their size. DCs were stimulated with β-glucan-coated beads overnight and were stained with Dectin-1 and DAPI.
(G) Wild-type DCs were stimulated with intact or fragmented wild-type hyphal C. albicans, pulsed with Ova peptide (323–339), and co-cultured with naïve Rag OT-II CD4+ T cells. Production of IL-9 was assessed by ELISA. n = 8 biological replicates.
Results are (B–D) mean ± SD or(E) mean ± SEM analyzed using two-way ANOVA followed by Tukey’s post hoc test. In(E), statistical comparisons are only shown for β-glucan-coated beads of various sizes and between genotypes. *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001; not significant if it is not denoted.
Figure 3.Duration of Dectin-1 signaling between small- versus large-target-stimulated DCs
(A) Confocal images showing surface Dectin-1 expression of DCs 5 min or 1 h after stimulating DCs with propidium-iodide-stained YLCA or HLCA (left). Relative quantification of the mean integrated density of Dectin-1 signal (right). n = 158 cells.
(B) DCs were stimulated with YLCA or HLCA for 5 min or 1 or 6 h. After stimulation, DCs were stained with fluorescein isothiocyanate (FITC)-labeled anti-Dectin-1 antibody. Representative histograms (left) show surface expression of Dectin-1 in DCs. Pooled percentages of Dectin-1low DCs from 3 independent experiments are shown (right). n = 3 biological replicates.
(C–D) Representative immunoblots showing phosphorylation of SYK and ERK in DCs that were stimulated for 5 or 30 min or 1,2,4, or 6 h with (C) YLCA or HLCA or (D) β-glucan-coated polystyrene beads (6 or 25 μm) (left). Quantification of phosphorylation of SYK and ERK (right). Data are representative of more than three independent experiments.
(E) Experimental plan for in vitro DC:OT-II T cell co-culture. Solid line represents persistent Dectin-1 signaling, and dotted line represents inhibited Dectin-1 signaling.
(F) DCs were stimulated with a β-glucan-coated plate for 1 h and treated with an SYK inhibitor (25 μM piceatannol) overnight. The next day, DCs were transferred to a fresh plate not coated with β-glucan and co-cultured with naïve Rag OT-II CD4+ T cells. Production of IL-9 was assessed by ELISA. n = 3 biological replicates.
Results are mean ± SD analyzed using one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001; not significant if it is not denoted.
Figure 4.Transcriptome analysis of DCs stimulated with large targets reveals a transcriptional signature favoring TH9 differentiation
(A) Experimental plan for DC activation and RNA-seq analysis.
(B) Heatmap depicting genes that are differentially expressed between DCs stimulated with small targets (β-glucan-coated 6 μm polystyrene beads or YLCA) and large targets (β-glucan-coated 25 μm polystyrene beads or HLCA). Down-regulated genes are shown in blue, and up-regulated genes are shown in red. Each column represents a biological replicate.
(C) Venn diagrams representing overlap of genes that are up- or down-regulated at least 2-fold relative to unstimulated DCs.
(D) Top 15 genes that are up-regulated in DCs stimulated with both β-glucan-coated 25 μm beads and HLCA.
(E) Heatmap of regulation of selected genes linked to TH9 polarization.
(F) qRT-PCR analysis of select TH9-associated gene transcripts. Data are represented as fold change in expression relative to unstimulated DCs. Genes are normalized to Gapdh transcript levels. n = 3 biological replicates.
Mean ± SD analyzed using one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001; not Significant if it is not denoted.
Figure 5.Increased expression of Il33 and key Tnfsf members in DCs stimulated with large targets is regulated by Dectin-1 but not by Dectin-2
(A–C) Wild-type and (A and B) Clec7a−/− or (C) Clec4n−/− DCs were stimulated overnight with (A and C) YLCA or HLCA or (B) β-glucan-coated 6 μm or 25 μm polystyrene beads. mRNA expression of selected cytokines driving TH9 differentiation was assessed by qRT-PCR. n = 4 biological replicates.
(D) Wild-type DCs were stimulated with heat-killed YLCA or HLCA overnight. mRNA expression of Il33 was assessed by qRT-PCR. n = 4 biological replicates.
(E) Wild-type DCs were stimulated with YLCA or HLCA overnight. DCs were lysed, and production of IL-33 was measured by ELISA. n = 3 biological replicates.
Results are mean ± SD analyzed using (A–C) two-way ANOVA or (D and E) one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001; not significant if it is not denoted.
Figure 6.IL-33 is a key cytokine driving TH9 polarization induced by DCs stimulated with large targets
(A) After transfecting Il33 siRNAs, DCs were stimulated with YLCA or HLCA overnight and pulsed with Ova peptide (323–339) for 2 h prior to being co-cultured with naïve Rag OT-II CD4+ T cells. Production of IL-9 was assessed by ELISA on day 3 of co-culture. Dots represent independent co-cultures. Data are representative data of 3 independent experiments.
(B) Schematic diagram of Dectin-1 signaling pathway and inhibitors of downstream proteins of Dectin-1 signaling.
(C) Wild-type and CARD9-deficient DCs were stimulated with PFA-fixed YLCA or HLCA overnight, and the expression of Il33 was measured by qRT-PCR and normalized to Gapdh. n = 4 biological replicates.
(D–G) DCs were treated with (D) Piceatannol, (E) U73122, (F) SB203580, or (G) U0126 1 h before stimulation with HLCA. The expression of Il33 was measured by qRT-PCR and normalized to Gapdh. n = 3 biological replicates.
Results are mean ± SD analyzed using (B) two-way ANOVA or (D–G) one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001; not significant if it is not denoted.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
|
| ||
| Antibodies | ||
|
| ||
| Alexa Fluor® 647 AffiniPure Goat Anti-Human IgG, Fcγ fragment specific | Jackson ImmunoResearch | Cat# 109-605-098; RRID: AB_2337889 |
| anti-mouse Dectin-1 | Bio-rad | Cat# MCA2289GA; RRID: AB_324905 |
| FITC conjugated anti-Dectin-1 antibody | Bio-rad | Cat#MCA2289FA; RRID: AB_566381 |
| GAPDH (6C5) antibody | Santa Cruz Biotechnology | Cat# sc-32233; RRID: AB_627679 |
| Goat Anti-Rabbit IgG (H+L) Antibody, Alexa Fluor 488 Conjugated | Invitrogen | Cat# A-11008; RRID: AB_143165 |
| p44/42 MAP kinase (phosphorylated Erk1/2) antibody | Cell Signaling Technology | Cat# 9101; RRID: AB_331646 |
| p44/42 MAPK (Erk1/2) Antibody | Cell Signaling Technology | Cat# 9102; RRID: AB_330744 |
| Phospho-Syk (Tyr525/526) (C87C1) Rabbit mAb antibody | Cell Signaling Technology | Cat# 2710; RRID: AB_2197222 |
| Syk Antibody | Cell Signaling Technology | Cat# 2712; RRID: AB_2197223 |
| TruStain FcX(TM) (anti-mouse CD16/32) antibody | BioLegend | Cat# 101319; RRID: AB_1574973 |
|
| ||
| Bacterial and virus strains | ||
|
| ||
| ( | N/A | |
| ( | N/A | |
| Δefg1/cph1 | ( | N/A |
| Δnrg1 | ( | N/A |
|
| ||
| Chemicals, peptides, and recombinant proteins | ||
|
| ||
| Corning™ Dulbecco’s Modification of Eagle’s Medium (DMEM) | Fisher Scientific | Cat# MT15017CV |
| DAPI | Sigma-Aldrich | Cat# D9542 |
| Fetal Bovine Serum | Sigma-Aldrich | Cat# F3018 |
| Gibco™ RPMI 1640 Medium, no glucose | Fisher Scientific | Cat# 11-879-020 |
| iTaq™ Universal Probes Supermix | Bio-rad | Cat# 1725132 |
| iTaq™ Universal SYBR® Green Supermix | Bio-rad | Cat# 1725122 |
| KODAK® BioMax® Maximum Resolution | VWR | Cat# IB-IB8701302 |
| (MR) Autoradiography Film | ||
| M-MLV Reverse Transcriptase (200 U/μL) | Invitrogen | Cat# 28025013 |
| Mannan from Saccharomyces cerevisiae | Sigma-Aldrich | Cat# M7504 |
| NuPAGE™ LDS Sample Buffer | Invitrogen | Cat# NP0007 |
| Ova 323-339 peptide | Anaspec | Cat# AS-27024; CAS: 92915-79-2 |
| p38 MAP Kinase Inhibitor (SB203580) | Invivogen | Cat# tlrl-sb20; CAS: 152121-47-6 |
| Paraformaldehyde | Sigma-Aldrich | Cat# 158127 |
| Piceatannol | Selleck Chemicals | Cat# S3026; CAS: 10083-24-6 |
| Pierce™ Protein-Free T20 (TBS) Blocking Buffer | Thermo Fisher Scientific | Cat# 37571 |
| Polybead® Microspheres 15.00μm | Polysciences | Cat# 18328 |
| Polybead® Microspheres 25.00μm | Polysciences | Cat# 07313 |
| Polybead® Microspheres 3.00μm | Polysciences | Cat# 17134 |
| Polybead® Microspheres 45.00μm | Polysciences | Cat# 07314 |
| Polybead® Microspheres 6.00μm | Polysciences | Cat# 07312 |
| Probumin® Bovine Serum Albumin Diagnostic Grade, Powder | Sigma-Aldrich | Cat# 820451 |
| Recombinant Human IgG1 Fc (Thr106-Lys330) (carrier-free) | Biolegend | Cat# 773006 |
| Recombinant Murine GM-CSF | Peprotech | Cat# 315-03; Accession# P01587 |
| Rhodamine Phalloidin | Invitrogen | Cat# R415 |
| Soluble murine Dectin-1 receptor | Invivogen | Cat# fc-mdec1a |
| SuperSignal™ West Pico PLUS Chemiluminescent Substrate | Thermo Fisher Scientific | Cat# 34580 |
| TRIzol™ Reagent | Invitrogen | Cat# 15596018 |
| U-73122 | Cayman Chemical | Cat# 70740; CAS: 112648-68-7 |
| U0126 | Tocris Bioscience | Cat# 1144; CAS: 109511-58-2 |
| WGP control / Dectin-1 inhibitor (soluble β-glucan) | Invivogen | Cat# tlrl-wgps |
| Zombie Violet™ Fixable Viability Kit | Biolegend | Cat# 423113 |
|
| ||
| Critical commercial assays | ||
|
| ||
| EasySep™ Mouse Naïve CD4+ T Cell Isolation Kit | Stem Cell Technologies | Cat# 19765 |
| ELISA MAX™ Deluxe Set Mouse IL-4 | Biolegend | Cat# 431106 |
| ELISA MAX™ Deluxe Set Mouse IL-9 | Biolegend | Cat# 442704 |
| ELISA MAX™ Standard Set Mouse IFN-γ | Biolegend | Cat# 430802 |
| ELISA MAX™ Standard Set Mouse IL-17A | Biolegend | Cat# 432503 |
| ELISA MAX™ Standard Set Mouse IL-6 | Biolegend | Cat# 431303 |
| ELISA MAX™ Standard Set Mouse TNF-α | Biolegend | Cat# 430903 |
| IL-13 Mouse Uncoated ELISA Kit | Invitrogen | Cat# 88-7137-88 |
| RNeasy Mini Kit | Qiagen | Cat# 74106 |
|
| ||
| Deposited data | ||
|
| ||
| Raw and analyzed data | This paper | GEO: GSE181734 |
|
| ||
| Experimental models: Organisms/strains | ||
|
| ||
| C57BL/6J | Jackson Laboratories | Strain# 000664; RRID:IMSR_JAX:000664 |
| Card9−/−; B6.129-Card9tm1Xlin/J | Jackson Laboratories | Strain #028652; RRID: IMSR_JAX:028652 |
| Celc6a−/− | ( | MGI:4459637 |
| Clec7a−/−; B6.129S6-Clec7atm1Gdb/J | Jackson Laboratories | Strain #012337; RRID: IMSR_JAX:012337 |
| Rag1−/−OT-II TCR; B6.129S7-Rag1tm1Mom Tg(TcraTcrb)425Cbn | Taconic Bioscience | Model# 4234; RRID:IMSR_TAC:4234 |
| Rag2−/−OT-II TCR; B6.129S6-Rag2tm1Fwa Tg(TcraTcrb)425Cbn | Taconic Bioscience | Model# 1896; RRID:IMSR_TAC:1896 |
|
| ||
| Oligonucleotides | ||
|
| ||
| For Custom Primer Sequences, see | ||
| FlexiTube GeneSolution GS77125 for Il33 | Qiagen GeneGlobe | Cat# 1027416; GeneGlobe Id: GS77125 |
|
| ||
| Software and algorithms | ||
|
| ||
| ComplexHeatmap (version 2.4.3) | ( | RRID:SCR_017270; |
| DESeq2 (version 1.28.1). | ( | RRID:SCR_015687; |
| FeatureCounts | ( | RRID:SCR_012919; |
| Fiji | ( | RRID:SCR_002285; |
| FlowJo version 10.1 (Tree star). | BD biosciences |
|
| Image J | ( | RRID:SCR_003070; |
| Image Lab | Bio-rad |
|
| qPCRsoft 3.4 | Analytik Jena | RRID:SCR_021910; |
| R (version 4.0.2) | R |
|
| Rsubread (version 2.2.6) | ( | RRID:SCR_009803; |
| STAR (Galaxy Version 2.7.7a) | ( |
|
| VennDiagram (version 1.6.20) | ( | RRID:SCR_002414; |
| ZEN 3.1 | ZEISS | RRID:SCR_013672; |